The contaminant chemical NDMA in Zantac pills is a substance that could cause cancer of the: pancreas (pancreatic cancer), stomach, colon, rectum (rectal cancer), bladder, or kidney (renal cancer). On April 1, 2020, the FDA announced that it was requesting a Zantac recall due to the presence of NDMA in Zantac and all other medications containing … [Read more...]
Ranitidine In Zantac Might Produce NDMA As A Result Of Heat Effect
There is a new Zantac-NDMA mechanism of action theory which suggests that when ranitidine is exposed to heat it produces unsafe levels of NDMA (nitrosamine impurity called N-nitrosodimethylamine), a probable human carcinogen. Ranitidine is the active ingredient in Zantac. From this January 2, 2020, Bloomberg news report about … [Read more...]
Zantac Cancer Lawsuits Filed After FDA Warnings About NDMA In Ranitidine
Zantac cancer lawsuits are for being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach. According to medical research, some of the cancers associated with Zantac use due to NDMA exposure include: Stomach cancerColon cancerRectal … [Read more...]